Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 4 completed trials

    Completion Rate
    100%(4/4)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 2
    4
    100%

    Phase Distribution

    0

    Early Stage

    4

    Mid Stage

    0

    Late Stage

    Phase Distribution4 total trials
    Phase 2Efficacy & side effects
    4(100.0%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    100.0%

    4 of 4 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    4

    all time

    Status Distribution
    Completed(4)

    Detailed Status

    Completed4

    Development Timeline

    Analytics

    Development Status

    Total Trials
    4
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 2

    Trials by Phase

    Phase 24 (100.0%)

    Trials by Status

    completed4100%

    Recent Activity

    0 active trials
    Showing 4 of 4
    completedphase_2

    Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan

    NCT00212693
    completedphase_2

    Effects of ONO-2506PO in Patients With Alzheimer's Disease

    NCT00083421
    completedphase_2

    Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)

    NCT00403104
    completedphase_2

    A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)

    NCT00694941

    Clinical Trials (4)

    Showing 4 of 4 trials
    NCT00212693Phase 2

    Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan

    Completed
    NCT00083421Phase 2

    Effects of ONO-2506PO in Patients With Alzheimer's Disease

    Completed
    NCT00403104Phase 2

    Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)

    Completed
    NCT00694941Phase 2

    A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)

    Completed

    All 4 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    4